Michael S. Weiss - Jul 5, 2023 Form 4 Insider Report for MUSTANG BIO, INC. (MBIO)

Role
Director
Signature
/s/ Matthew Wein, Attorney-in-Fact
Stock symbol
MBIO
Transactions as of
Jul 5, 2023
Transactions value $
$0
Form type
4
Date filed
7/7/2023, 04:06 PM
Previous filing
Jun 15, 2023
Next filing
Aug 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBIO COMMON STOCK, PAR VALUE $0.0001 Award $0 +7.25K +17.09% $0.00 49.6K Jul 5, 2023 See Footnote F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 7,246 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 5, 2023. The shares will vest on July 5, 2026, subject to the Reporting Person's continued service on the Issuer's board on such date.
F2 Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.
F3 Includes restricted share units, which vest over various time periods.
F4 The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member.